Clinical Trial Design Considerations for Small Populations in Rare Kidney Disease

• Building multi-stakeholder alignment to advance clinical trial design in small kidney disease populations
• Moving beyond the status quo with bold, innovative approaches for rare population trials
• Embedding patient voice and pragmatic design principles to make trials feasible and meaningful

Speakers:

Jennifer McKenzie

Senior Clinical Program Leader

Boehringer Ingelheim